- Home
- ELSE vs LPCN Comparison
ELSE vs LPCN Comparison
Compare ELSE & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELSE
- LPCN
- Stock Information
- Founded
- ELSE 1968
- LPCN 1997
- Country
- ELSE United States
- LPCN United States
- Employees
- ELSE N/A
- LPCN N/A
- Industry
- ELSE Industrial Machinery/Components
- LPCN Biotechnology: Pharmaceutical Preparations
- Sector
- ELSE Industrials
- LPCN Health Care
- Exchange
- ELSE Nasdaq
- LPCN Nasdaq
- Market Cap
- ELSE 16.2M
- LPCN 16.4M
- IPO Year
- ELSE N/A
- LPCN N/A
- Fundamental
- Price
- ELSE $4.37
- LPCN $3.44
- Analyst Decision
- ELSE
- LPCN Strong Buy
- Analyst Count
- ELSE 0
- LPCN 1
- Target Price
- ELSE N/A
- LPCN $10.00
- AVG Volume (30 Days)
- ELSE 5.7K
- LPCN 16.6K
- Earning Date
- ELSE 03-19-2025
- LPCN 05-08-2025
- Dividend Yield
- ELSE N/A
- LPCN N/A
- EPS Growth
- ELSE 29.91
- LPCN N/A
- EPS
- ELSE 0.13
- LPCN N/A
- Revenue
- ELSE $9,289,000.00
- LPCN $7,922,926.00
- Revenue This Year
- ELSE N/A
- LPCN N/A
- Revenue Next Year
- ELSE N/A
- LPCN N/A
- P/E Ratio
- ELSE $34.05
- LPCN N/A
- Revenue Growth
- ELSE 11.21
- LPCN N/A
- 52 Week Low
- ELSE $3.75
- LPCN $2.91
- 52 Week High
- ELSE $5.50
- LPCN $11.79
- Technical
- Relative Strength Index (RSI)
- ELSE 36.28
- LPCN 44.34
- Support Level
- ELSE $4.40
- LPCN $2.91
- Resistance Level
- ELSE $4.70
- LPCN $3.62
- Average True Range (ATR)
- ELSE 0.17
- LPCN 0.22
- MACD
- ELSE -0.01
- LPCN 0.06
- Stochastic Oscillator
- ELSE 13.56
- LPCN 63.70
About ELSE Electro-Sensors Inc.
Electro-Sensors Inc is engaged in manufacturing and selling a variety of monitoring systems that measure actual machine production and operation rates, as well as systems that regulate the speed of related machines in production processes. Its speed monitoring systems compare revolutions per minute or speed against acceptable rates as determined by a customer. It also includes a line of products that measure production counts or rates, such as parts, gallons, or board feet, alarm systems, tachometers, and other devices that translate impulses from the sensors into alarm signals, computer inputs, or digital displays that are usable by the customer.
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.